RISE-PD Full Data Highlight IPX203’s Impa... - Cure Parkinson's
RISE-PD Full Data Highlight IPX203’s Impact as Promising Parkinson Treatment
Written by
Farooqji
To view profiles and participate in discussions please or .
6 Replies
•
extended-release carbidopa-levodopa (CD/LD)
Indeed, it seems like old wine in new bottles. Moreover, the comparison with IR CD-LD is comparing apples with oranges. One would think that a comparison with ER CD-LD would make more sense, but of course the outcome would then be somewhat less spectacular. Yet the following study shows that when comparing with Rytary, there is indeed an interesting difference, because IPX203 has a significantly longer pharmacodynamic effect.
Worry is that cost will be high making insurers reluctant in the US and unavailable in UK. Only useful if available
Not what you're looking for?
You may also like...
Clinical Stabilization in Parkinson´s Disease: The Multi-Target Treatment Description and Results
Here is an interesting article entitled,
Clinical Stabilization in Parkinson´s Disease: The...
Osteoporosis and PD - Looking for natural treatment options for OP that doesn't impact PD meds and supplements
Hi all,
I am 57 diagnosed over 3 years ago with PD. I take L/C and most of the supplements...
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease - 2019
Hats off to sunvox for having mentioned Trehalose a few times in these forums...
WHICH WOULD YOU CONSIDER AS THE MOST BENEFICIAL TO YOU AS A PD TREATMENT? MEDICATION OR DBS.
Hi fellow parkies and caregivers.For patients and caregivers,your opinions we go a long way to help...
Does anyone with 8 to 12 years of DX with Parkinson"s feel that they have their PD almost completely under control.
If you feel you do please list your symptoms and meds and what ever you do to control your PD. ...